Health Trials

Vascular Lesion

3

Review clinical trials related to Vascular Lesion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases

The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Beijing Anzhen HospitalUpdated: Jun 12, 2025Locations: 1Duration: 1 Year
Eligibility criteria

Age ≥18 years; [+1]

The expected survival is less than 1 years; [+1]

Read more
Status: Recruiting

Oxygenation in Vascular Lesions of the Colon

The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.

Participants needed: 30
Trial details
Age: 18-89Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Jun 10, 2025Locations: 1
Eligibility criteria

Undergo standard of care colonoscopy [+3]

Age < 18 years [+3]

Read more
Status: Recruiting

Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat skin disorders: * Excessive Hairiness (Hirsutism, Hypertrichosis...) * Vascular lesions (Rosacea….) * Pigmented lesions (Lentigo et melasma) * Acne vulgaris

Participants needed: 85
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: EurofeedbackUpdated: Oct 23, 2024Locations: 5
Eligibility criteria

Adult men or women [+14]

Patients with history of malignant lesions or pre-malignant lesions, scarring, o... [+12]

Read more